Search
Taysha Gene Therapies Inc
TSHAAdd to Watchlist
5.860USD
-0.015-0.26%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.87BMarket Cap
LossP/E TTM
Taysha Gene Therapies Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Taysha Gene Therapies Inc is 8.53, ranking 87 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -15.56, which is -132.92% below the recent high of 5.12 and -31.60% above the recent low of -20.47.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.